1708. Application of the Desirability of Outcome Ranking (DOOR) Strategy to Evaluate Outcomes in Patients with S. aureus Bacteremia
Session: Meet-the-Professor Session: Evaluating the Outcomes of Staphylococcus aureus Bacteremia: Use of the DOOR Strategy
Saturday, October 29, 2016: 7:00 AM
Room: 383-385
Thomas Holland, MD, MSc-GH, Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC


Disclosures:

T. Holland, Basilea Pharmaceutica: Consultant , Consulting fee
The Medicines Company: Consultant , Consulting fee

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.